在COPD试验结果呈阳性后,阿斯特拉泽内卡的股价上. AstraZeneca shares rose after positive COPD trial results.

在该公司宣布临床试验的积极结果后,阿斯特拉泽内卡股价上. 该试验涉及慢性阻塞性肺病新疗法. AstraZeneca shares climbed after the company announced positive results from a clinical trial involving a new treatment for Chronic Obstructive Pulmonary Disease.